Emory Evaluating New Therapies for Patients with AFib, First in GA
February 27, 2017
February 27, 2017
ATLANTA, Feb. 27 -- Emory University's Woodruff Health Sciences Center issued the following news release:
Researchers at the Emory Heart & Vascular Center are the first in Georgia to participate in two clinical trials evaluating new treatment options for patients with atrial fibrillation (AFib).
Both trials, commonly referred to as the AMAZE and Amulet trials, are assessing methods to close off the heart's left atrial appendage (LAA), a muscular pouch connected . . .
Researchers at the Emory Heart & Vascular Center are the first in Georgia to participate in two clinical trials evaluating new treatment options for patients with atrial fibrillation (AFib).
Both trials, commonly referred to as the AMAZE and Amulet trials, are assessing methods to close off the heart's left atrial appendage (LAA), a muscular pouch connected . . .